Early palliative and supportive care referral is the standard of care for many malignancies. This paradigm results in improvements in patients' symptoms and quality of life and decreases the costs of medical care and unnecessary procedures. Leading oncology guidelines have recommended the integration of early referral to palliative and supportive services to care pathways for advanced malignancies. Currently, early referral to palliative care within the hepatocellular carcinoma (HCC) population is not utilized, with gastroenterology guidelines recommending referral of patients with Barcelona Clinic Liver Cancer stage D to these services. This review addresses this topic through analysis of the existing data within the oncology field as well as literature surrounding palliative care intervention in HCC. Early palliative and supportive care in HCC and its impact on patients, caregivers, and health services allow clinicians and researchers to identify management options that improve outcomes within existing service provisions.

早期姑息治疗和支持治疗转诊是许多恶性肿瘤的标准治疗。这种模式导致患者症状和生活质量的改善，并降低了医疗费用和不必要的程序。领先的肿瘤学指南建议将早期转诊纳入姑息治疗和支持服务，以治疗晚期恶性肿瘤。目前，肝细胞癌 (HCC) 人群未采用早期转诊至姑息治疗，胃肠病学指南建议将巴塞罗那诊所肝癌 D 期患者转诊至这些服务。本综述通过分析肿瘤学领域的现有数据以及围绕 HCC 姑息治疗干预的文献来解决该主题。